These results are consistent with the previous findings, which suggested a positive association between positive immunostaining for MMP-9 and older age (≥45 years), advanced clinical stage (III–IV), and larger tumor diameter (≥2 cm) in PTC [33]. Here, MMP9 is linked to neoplasm.